Rpg Investment Advisory, LLC Dexcom Inc Transaction History

Rpg Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 06, 2018	SELL	$17.54 - $25.22 $1.17 Million - $1.69 Million	-66,906 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $21,235 - $30,146	1,626 Added 2.49%	66,906 $4.96 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $74,604 - $103,184	6,709 Added 11.45%	65,280 $3.75 Million
Q3 2017 Feb 05, 2019	BUY	$11.36 - $18.98 $9,156 - $15,297	806 Added 1.4%	58,571 $2.87 Million
Q2 2017 Feb 04, 2019	BUY	N/A	57,765	57,765 $4.23 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Rpg Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rpg Investment Advisory, LLC with notifications on news.